Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Hypertension
Interventions
DRUG

Clonidine controlled-release patch

"Enrolled patients receive clonidine patch (2.5 mg), once a week. The doses are doubled, if the office systolic BP not at goal (\<140 mmHg) at 4 weeks.~All patients receive smoking cessation advice at the beginning, and smoking cessation promotion information is pushed by WeChat three times during the observation period (weeks 2, 4 and 6)."

DRUG

Amlodipine

"Enrolled patients receive amlodipine (5 mg), once daily. The doses are doubled, if the office systolic BP not at goal (\<140 mmHg) at 4 weeks.~All patients receive smoking cessation advice at the beginning, and smoking cessation promotion information is pushed by WeChat three times during the observation period (weeks 2, 4 and 6)."

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Jing Liu

OTHER

NCT05416840 - Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension | Biotech Hunter | Biotech Hunter